Brief: PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway
Jan 6 (Reuters) - Pci Biotech Holding Asa PCIB.OL :
* The PCI Biotech and Ultimovacs collaboration awarded
500,000 Norwegian crowns ($58,869.24) from Innovation Norway
* The Innovation Norway grant of 500,000 crowns is awarded
for 2017 and the grant is made available through Oslo Cancer
Cluster a Norwegian Centre of Expertise
Source text for Eikon: ID:nGNE59Z4XV
Further company coverage: PCIB.OL
($1 = 8.4934 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process